ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 351

Risk Factors for Cutaneous Reactions to Allopurinol in Kinh Vietnameses: Results of a Prospective Study in Ho Chi Minh City

Thomas Bardin1, Linh Gia Le 2, Quang Dinh Nguyen 3, Anh Duy Do 4, Hung Le 5, Minh Duc Do 2, Anh Hoang Vu 2, Anh Ngoc Le 6, Kim Minh Bui 3, Pascal Richette 7, Matthieu Resche-Rigon 8 and Thao Phuong Mai 9, 1Vien Gut Medical Center and hopital Lariboisiere, Paris, France, 2Center for Molecular Biomedicine, University of Medicine and Pharmacy HCMC, Vietnam, Ho Chi Minh City, Vietnam, 3Vien Gut Medical Center, Ho Chi Minh City, Vietnam, 4Department of Physiology, Pathophysiology and Immunology - Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam, 5Department of Tropical Disease - Cho Ray Hospital, Ho Chi Minh City, Vietnam, 6Departement of Scientific Research, Cho Ray Hospital, Ho Chi Minh City, Vietnam, 7Department of Rheumatology, AP-HP Lariboisiere Hospital, Paris, France, 8Departe;ent of Biostatistics Hopital St Louis, Paris, France, 9Department of Physiology, Faculty of Medicine, University of Medicine and Pharmacy HCMC, Vietnam, Ho Chi Minh City, Vietnam

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: gout, radiography and allopurinol

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Metabolic & Crystal Arthropathies Poster I: Clinical

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose:  Allopurinol (ALLO), the leading hypouricemic drug worldwide, exposes to mild (M) and severe (S) cutaneous adverse reactions (CARs). SCARS have been associated with HLA*B-58 01. However, the reported strength of the association has varied across ethnicities and has been little studied in Vietnam. Little is known about risk factors for MCARs.
 The aim of this prospective study was to investigate risk factors, including HLA*B-58 01, for MCARs and SCARs in the predominant Kinh ethnicity of Vietnam.

Methods:  All patients were Kinh Vietnamese and were prospectively recruited in Ho Chi Minh City, after Ethics committee approval. SCARs were recruited in dermatology and allergy hospital departments, MCARs in the same departments and at the Vien Gut clinic (specialized in gout care), and tolerant gouty patients (no skin reaction after at least 3 months from the last increment in ALLO dose) at the Vien Gut clinic. Clinical data were prospectively collected and HLA*B-58 01 genotype was obtained using the PG5801 DNA detection kit (Pharmigene-Taiwan). Fisher exact test for categorical variables and Kruskal/Wilkonson test for quantitative variables were used for statistics.

Results: Between March 2017 and May 2019, 31 patients with a non-fatal SCAR. (29 toxic necrotic epidermolysis/ Stevens-Johnson syndrome and 2 DRESS), 74 patients who stopped ALLO because of MCAR and 395 ALLO-tolerant patients were recruited. Table 1 shows the main features of interest in the 3 groups. The Odds ratios of lack of dose escalation, HLA*B-58 01 presence and GFR< 60 ml/min to develop SCARs were calculated at 883 (, 95%CI:128; 4504), 185(95 % CI: 43; 1595) and 104 (95%CI:28;454), respectively.

Conclusion: In the studied Vietnamese Kinh population, lack of ALLO titration was the strongest risk factor for SCARs. HLA*B-58 01 and other known factors, including renal failure but not high ALLO dose, were also significantly associated with SCARs. MCARs associated with lack of ALLO titration and renal failure but not with HLA*B-58 01


table abstract ACR 2019

Table 1: Factors associated with SCARs and MCARS to ALLO in the Kinh population of Ho Chi Minh City -Vietnam-


Disclosure: T. Bardin, None; L. Le, None; Q. Nguyen, None; A. Do, None; H. Le, None; M. Do, None; A. Vu, None; A. Le, None; K. Bui, None; P. Richette, Janssen, 8; M. Resche-Rigon, None; T. Mai, None.

To cite this abstract in AMA style:

Bardin T, Le L, Nguyen Q, Do A, Le H, Do M, Vu A, Le A, Bui K, Richette P, Resche-Rigon M, Mai T. Risk Factors for Cutaneous Reactions to Allopurinol in Kinh Vietnameses: Results of a Prospective Study in Ho Chi Minh City [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/risk-factors-for-cutaneous-reactions-to-allopurinol-in-kinh-vietnameses-results-of-a-prospective-study-in-ho-chi-minh-city/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-for-cutaneous-reactions-to-allopurinol-in-kinh-vietnameses-results-of-a-prospective-study-in-ho-chi-minh-city/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology